Article Details

Alnylam's RNAi Therapies Make It A Buy

Retrieved on: 2020-11-28 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Alnylam's RNAi Therapies Make It A Buy. View article details on hiswai:

Excerpt

... including small molecules and <b>monoclonal antibodies</b>. The table shows that Alnylam has direct competition in several areas. Ionis (NASDAQ:IONS) ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up